37.31
+0.04000137(+0.11%)
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
1545
First IPO Date
May 20, 2021
| Name | Title | Pay | Year Born |
| Ms. Zhou Hua | Secretary of Board | 0 | 1978 |
| Mr. Wei Ding | Financial Director | 0 | 1983 |
| Mr. Guoqiang Shi | Senior Vice President & Director | 0 | 1961 |
| Yanwen Chen | Accounting Supervisor | 0 | N/A |
| Dr. Jianjun Jiang Ph.D. | Vice President | 0 | 1956 |
| Mr. Xiaohua Li | Senior Vice President | 0 | 1981 |
| Mr. Ziquan Tong | GM & Chairman | 0 | 1970 |
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd., a biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China. The company offers formulations, such as thymalfasin products for injection, eptifibatide injections, alogliptin benzoate tablets, and oseltamivir phosphate capsules; APIs and intermediates; and drugs for type 2 diabetes and obesity, and coronavirus. It also provides pharmaceutical research, clinical, and registration services of drugs; and undertakes CDMO/CMO projects of small molecule chemical API and intermediates. The company was founded in 2009 and is headquartered in Hangzhou, China.
